Stock Markets January 26, 2026

Medicare Advantage Rate Proposal Sends Major Insurer Shares Lower

CMS preliminary plan for 2027 would raise payments by just 0.09% on average, prompting steep after-hours drops for CVS, UnitedHealth and Humana

By Nina Shah CVS UNH HUM
Medicare Advantage Rate Proposal Sends Major Insurer Shares Lower
CVS UNH HUM

Shares of large health insurers fell sharply in after-hours trading after a federal proposal outlined a much smaller than expected increase in Medicare Advantage payment rates for 2027. The Centers for Medicare and Medicaid Services is reported to be proposing an average 0.09% increase and measures to curb a billing practice under scrutiny, with the formal notice expected shortly and final rates set after industry comment.

Key Points

  • CMS is reported to propose an average 0.09% increase to Medicare Advantage payments for 2027, a move that triggered steep after-hours declines for major insurers.
  • The proposed increase equates to approximately $700 million for the industry and is far below analyst expectations of 4% to 6%, and below the 5.06% increase insurers received for the current year.
  • The proposal also seeks to remove a billing practice described as lucrative and under watchdog scrutiny, with CMS citing goals of payment accuracy, appropriate reimbursement, simplicity, and competition.

Shares of major health insurers plunged in after-hours trading Monday following a report that the Trump administration plans to propose substantially lower Medicare Advantage payment rates for 2027 than analysts had expected.

CVS Health (NYSE:CVS) and UnitedHealth Group (NYSE:UNH) each declined by about 8% in extended trading, while Humana (NYSE:HUM) fell roughly 10%, according to market moves reported after the closing bell. The sell-off followed reporting that the Centers for Medicare and Medicaid Services intends to increase payments to Medicare Advantage plans by only 0.09% on average next year.

The proposed average increase would translate to roughly $700 million in additional payments to the industry - a figure that is materially below consensus forecasts. Analysts had been pricing in rate increases in the range of 4% to 6%, while insurers received a 5.06% boost for the current year.

In addition to the modest average increase, the agency is said to be moving to eliminate what the reporting described as a "lucrative industry billing practice" that has drawn scrutiny from government watchdogs. A Medicare official quoted in the report framed the proposal as an effort to improve payment accuracy and ensure appropriate reimbursement, with an emphasis on simplicity, competition, and accuracy in the billing framework.

Medicare Advantage plans - private plan alternatives to traditional Medicare - comprise central businesses for the affected insurers, making federal payment policy an important determinant of their financial results. Because these plans are core segments, proposed federal rate changes and billing-rule adjustments can directly affect revenue trajectories tied to those businesses.

The report indicated that the CMS official announcement was expected Monday. The action would take the form of a preliminary rate notice; final rates are typically published in April after a period during which the industry may submit feedback.


Context and implications

The information released so far is confined to the preliminary proposal and the descriptions provided by officials quoted in the report. The proposal’s status as a preliminary notice means it remains subject to change before final rates are determined in the spring after the formal comment period.

Risks

  • This remains a preliminary rate notice - final payment rates are subject to revision through the formal comment process and are not finalized until April, creating uncertainty for insurers and investors.
  • Reduced Medicare Advantage payment growth and changes to billing practices could materially affect revenue in insurers’ core Medicare Advantage businesses, impacting insurers' near-term financial performance.
  • Market reaction to the proposal could add volatility to the health insurance sector, affecting equity valuations and potentially funding or capital considerations for the companies involved.

More from Stock Markets

Tesla Debuts New All-Wheel Drive Model Y Trim in U.S.; Premium Option Also Launched Feb 2, 2026 Eastroc Beverage Shares Start Trading in Hong Kong at Offer Price After $1.3 Billion IPO Feb 2, 2026 SoftBank unit and Intel to jointly develop 'Z-Angle' memory technology Feb 2, 2026 M EVO GLOBAL ACQUISITION CORP II Raises $300 Million in IPO Aimed at Critical Minerals Deals Feb 2, 2026 NRW Holdings Shares Rise After Securing A$175m Rio Tinto Earthworks Contract Feb 2, 2026